Matrix metalloproteinases (MMPs), the most important ECM‐degrading enzyme in vivo, plays an influential part in cerebral ischemia/reperfusion, especially when the expression and activity of matrix metalloproteinase‐9 (MMP‐9) increases in ischemic brain tissue. The gene discussed is MMP9; the disease is Cerebral ischemia.